Thanks @dunny29 - Early contender for post of the week
I guess once we get the Initial Jorc then we can naturally shift focus to the impending Scoping Study with good discussion
Exciting times for all shareholders!
- Forums
- ASX - By Stock
- CLA
- Scoping Study & Capex - Sulphides vs Laterites, Why CLA is so well positioned
CLA
celsius resources limited.
Add to My Watchlist
7.69%
!
0.7¢

Scoping Study & Capex - Sulphides vs Laterites, Why CLA is so well positioned, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $21.94M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $854 | 122K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
35 | 16677406 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 2848645 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 15844073 | 0.006 |
21 | 11916353 | 0.005 |
4 | 2760009 | 0.004 |
5 | 4070000 | 0.003 |
5 | 5900001 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 2848645 | 3 |
0.008 | 2911324 | 8 |
0.009 | 9032380 | 7 |
0.010 | 2781001 | 9 |
0.011 | 4725263 | 4 |
Last trade - 15.20pm 03/07/2025 (20 minute delay) ? |
Featured News
CLA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online